Evaluating the oncologic impact of statin use in gynecologic cancers: a critical review of pre-clinical and clinical evidence
- 18 January 2026
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (5) , 104495
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Is there sufficient evidence to recommend women diagnosed with endometrial cancer take a statin: Results from an Australian record-linkage studyGynecologic Oncology, 2021
- Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort studyInternational Journal of Cancer, 2018
- Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancerGynecologic Oncology, 2017
- Statin use and mortality among ovarian cancer patients: A population‐based cohort studyInternational Journal of Cancer, 2017
- National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013JAMA Cardiology, 2017
- Statin use and survival in elderly patients with endometrial cancerGynecologic Oncology, 2015
- Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerGynecologic Oncology, 2014
- The effect of statins on risk and survival of gynecological malignanciesGynecologic Oncology, 2013
- Impact of statin therapy on survival in epithelial ovarian cancerGynecologic Oncology, 2008
- A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervixEuropean Journal of Cancer, 2005